Ocugen Inc (OCGN)
1.33
+0.01
(+0.76%)
USD |
NASDAQ |
May 03, 16:00
1.37
+0.04
(+3.01%)
After-Hours: 20:00
Ocugen Cash from Financing (TTM): 20.88M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 20.88M |
September 30, 2023 | 29.04M |
June 30, 2023 | 30.04M |
March 31, 2023 | 14.87M |
December 31, 2022 | 59.48M |
September 30, 2022 | 51.90M |
June 30, 2022 | 51.05M |
March 31, 2022 | 144.48M |
December 31, 2021 | 120.68M |
September 30, 2021 | 129.54M |
June 30, 2021 | 136.24M |
March 31, 2021 | 57.42M |
December 31, 2020 | 31.61M |
September 30, 2020 | 23.05M |
June 30, 2020 | 41.85M |
March 31, 2020 | 25.23M |
December 31, 2019 | 25.07M |
September 30, 2019 | 41.52M |
June 30, 2019 | 18.44M |
Date | Value |
---|---|
March 31, 2019 | 20.18M |
December 31, 2018 | 25.35M |
September 30, 2018 | 7.845M |
June 30, 2018 | 5.166M |
March 31, 2018 | 5.064M |
December 31, 2017 | -0.577M |
September 30, 2017 | -0.622M |
June 30, 2017 | 27.05M |
March 31, 2017 | 27.05M |
December 31, 2016 | 27.05M |
September 30, 2016 | 27.09M |
June 30, 2016 | -0.557M |
March 31, 2016 | -0.499M |
December 31, 2015 | 4.371M |
September 30, 2015 | 66.21M |
June 30, 2015 | 65.99M |
March 31, 2015 | 76.01M |
December 31, 2014 | 71.05M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
14.87M
Minimum
Mar 2023
144.48M
Maximum
Mar 2022
55.39M
Average
41.52M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
QuidelOrtho Corp | -265.80M |
Johnson & Johnson | -21.42B |
Akebia Therapeutics Inc | -25.21M |
Shockwave Medical Inc | 600.40M |
iBio Inc | 10.68M |